Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study

go back to reference Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241: 2035-2038. 10.1001/jama.1979.03290450033020.CrossRefPubMed Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979, 241: 2035-2038. 10.1001/jama.1979.03290450033020.CrossRefPubMed

go back to reference Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007, 116: e418-e499. 10.1161/CIRCULATIONAHA.107.185699.CrossRefPubMed Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. 2007, 116: e418-e499. 10.1161/CIRCULATIONAHA.107.185699.CrossRefPubMed

go back to reference Valenta I, Dilsizian V, Quercioli A, Schelbert HR, Schindler TH: The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow. Curr Cardiol Rep. 2011, 14: 217-225.CrossRef Valenta I, Dilsizian V, Quercioli A, Schelbert HR, Schindler TH: The Influence of Insulin Resistance, Obesity, and Diabetes Mellitus on Vascular Tone and Myocardial Blood Flow. Curr Cardiol Rep. 2011, 14: 217-225.CrossRef

go back to reference Setty S, Sun W, Martinez R, Downey HF, Tune JD: Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. J Appl Physiol. 2004, 97: 431-438. 10.1152/japplphysiol.01122.2003.CrossRefPubMed Setty S, Sun W, Martinez R, Downey HF, Tune JD: Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus. J Appl Physiol. 2004, 97: 431-438. 10.1152/japplphysiol.01122.2003.CrossRefPubMed

go back to reference Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000, 87: 840-844. 10.1161/01.RES.87.10.840.CrossRefPubMed Cai H, Harrison DG: Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000, 87: 840-844. 10.1161/01.RES.87.10.840.CrossRefPubMed

go back to reference Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001, 88: E14-E22. 10.1161/01.RES.88.2.e14.CrossRefPubMed Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001, 88: E14-E22. 10.1161/01.RES.88.2.e14.CrossRefPubMed

go back to reference Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJHM, Stehouwer CDA, Smulders YM, van Hinsbergh VWM: Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord. 2013, 14: 39-48. 10.1007/s11154-013-9239-7.CrossRefPubMed Eringa EC, Serne EH, Meijer RI, Schalkwijk CG, Houben AJHM, Stehouwer CDA, Smulders YM, van Hinsbergh VWM: Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes. Rev Endocr Metab Disord. 2013, 14: 39-48. 10.1007/s11154-013-9239-7.CrossRefPubMed

go back to reference Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR: Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation. 2005, 111: 2291-2298. 10.1161/01.CIR.0000164232.62768.51.CrossRefPubMed Prior JO, Quiñones MJ, Hernandez-Pampaloni M, Facta AD, Schindler TH, Sayre JW, Hsueh WA, Schelbert HR: Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation. 2005, 111: 2291-2298. 10.1161/01.CIR.0000164232.62768.51.CrossRefPubMed

go back to reference Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G: Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation. 1999, 100: 813-819. 10.1161/01.CIR.100.8.813.CrossRefPubMed Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G: Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation. 1999, 100: 813-819. 10.1161/01.CIR.100.8.813.CrossRefPubMed

go back to reference Di Carli MF, Janisse J, Grunberger G, Ager J: Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003, 41: 1387-1393. 10.1016/S0735-1097(03)00166-9.CrossRefPubMed Di Carli MF, Janisse J, Grunberger G, Ager J: Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003, 41: 1387-1393. 10.1016/S0735-1097(03)00166-9.CrossRefPubMed

go back to reference Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG: Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology. 1990, 72: 659-662. 10.1097/00000542-199004000-00014.CrossRefPubMed Bernard JM, Wouters PF, Doursout MF, Florence B, Chelly JE, Merin RG: Effects of sevoflurane and isoflurane on cardiac and coronary dynamics in chronically instrumented dogs. Anesthesiology. 1990, 72: 659-662. 10.1097/00000542-199004000-00014.CrossRefPubMed

go back to reference Crystal GJ, Zhou X, Gurevicius J, Czinn EA, Salem MR, Alam S, Piotrowski A, Hu G: Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology. 2000, 92: 1103-1113. 10.1097/00000542-200004000-00029.CrossRefPubMed Crystal GJ, Zhou X, Gurevicius J, Czinn EA, Salem MR, Alam S, Piotrowski A, Hu G: Direct coronary vasomotor effects of sevoflurane and desflurane in in situ canine hearts. Anesthesiology. 2000, 92: 1103-1113. 10.1097/00000542-200004000-00029.CrossRefPubMed

go back to reference Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K: Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg. 1992, 74: 79-88.CrossRefPubMed Conzen PF, Vollmar B, Habazettl H, Frink EJ, Peter K, Messmer K: Systemic and regional hemodynamics of isoflurane and sevoflurane in rats. Anesth Analg. 1992, 74: 79-88.CrossRefPubMed

go back to reference Hirano M, Fujigaki T, Shibata O, Sumikawa K: A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg. 1995, 80: 651-656.PubMed Hirano M, Fujigaki T, Shibata O, Sumikawa K: A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg. 1995, 80: 651-656.PubMed

go back to reference Manohar M, Parks CM: Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anesthesia without and with 50% nitrous oxide. J Pharmacol Exp Ther. 1984, 231: 640-648.PubMed Manohar M, Parks CM: Porcine systemic and regional organ blood flow during 1.0 and 1.5 minimum alveolar concentrations of sevoflurane anesthesia without and with 50% nitrous oxide. J Pharmacol Exp Ther. 1984, 231: 640-648.PubMed

go back to reference Larach DR, Schuler HG: Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 1991, 75: 268-278. 10.1097/00000542-199108000-00015.CrossRefPubMed Larach DR, Schuler HG: Direct vasodilation by sevoflurane, isoflurane, and halothane alters coronary flow reserve in the isolated rat heart. Anesthesiology. 1991, 75: 268-278. 10.1097/00000542-199108000-00015.CrossRefPubMed

go back to reference Bulte CSE, Slikkerveer J, Kamp O, Heymans MW, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA: General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg. 2013, 116: 767-774. 10.1213/ANE.0b013e31827e4e41.CrossRefPubMed Bulte CSE, Slikkerveer J, Kamp O, Heymans MW, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA: General anesthesia with sevoflurane decreases myocardial blood volume and hyperemic blood flow in healthy humans. Anesth Analg. 2013, 116: 767-774. 10.1213/ANE.0b013e31827e4e41.CrossRefPubMed

go back to reference Bulte CSE, Slikkerveer J, Meijer RI, Gort D, Kamp O, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA: Contrast-enhanced ultrasound for myocardial perfusion imaging. Anesth Analg. 2012, 114: 938-945. 10.1213/ANE.0b013e318248e261.CrossRefPubMed Bulte CSE, Slikkerveer J, Meijer RI, Gort D, Kamp O, Loer SA, de Marchi SF, Vogel R, Boer C, Bouwman RA: Contrast-enhanced ultrasound for myocardial perfusion imaging. Anesth Analg. 2012, 114: 938-945. 10.1213/ANE.0b013e318248e261.CrossRefPubMed

go back to reference Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115: 387-397. 10.1161/CIRCULATIONAHA.106.634949.CrossRefPubMed Vinik AI, Ziegler D: Diabetic cardiovascular autonomic neuropathy. Circulation. 2007, 115: 387-397. 10.1161/CIRCULATIONAHA.106.634949.CrossRefPubMed

go back to reference Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C: The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005, 45: 754-762. 10.1016/j.jacc.2004.11.044.CrossRefPubMed Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C: The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol. 2005, 45: 754-762. 10.1016/j.jacc.2004.11.044.CrossRefPubMed

go back to reference Madonna R, De Caterina R: Cellular and molecular mechanisms of vascular injury in diabetes–part I: pathways of vascular disease in diabetes. Vascul Pharmacol. 2011, 54: 68-74. 10.1016/j.vph.2011.03.005.CrossRefPubMed Madonna R, De Caterina R: Cellular and molecular mechanisms of vascular injury in diabetes–part I: pathways of vascular disease in diabetes. Vascul Pharmacol. 2011, 54: 68-74. 10.1016/j.vph.2011.03.005.CrossRefPubMed

go back to reference Picchi A, Limbruno U, Focardi M, Cortese B, Micheli A, Boschi L, Severi S, De Caterina R: Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. Am J Physiol Heart Circ Physiol. 2011, 301: H2279-H2284. 10.1152/ajpheart.00615.2011.CrossRefPubMed Picchi A, Limbruno U, Focardi M, Cortese B, Micheli A, Boschi L, Severi S, De Caterina R: Increased basal coronary blood flow as a cause of reduced coronary flow reserve in diabetic patients. Am J Physiol Heart Circ Physiol. 2011, 301: H2279-H2284. 10.1152/ajpheart.00615.2011.CrossRefPubMed

go back to reference Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G: Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol. 2008, 7: 26-10.1186/1475-2840-7-26.PubMedCentralCrossRefPubMed Cosyns B, Droogmans S, Hernot S, Degaillier C, Garbar C, Weytjens C, Roosens B, Schoors D, Lahoutte T, Franken PR, Van Camp G: Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats. Cardiovasc Diabetol. 2008, 7: 26-10.1186/1475-2840-7-26.PubMedCentralCrossRefPubMed

go back to reference Akata T, Izumi K, Nakashima M: The action of sevoflurane on vascular smooth muscle of isolated mesenteric resistance arteries (part 2): mechanisms of endothelium-independent vasorelaxation. Anesthesiology. 2000, 92: 1441-1453. 10.1097/00000542-200005000-00035.CrossRefPubMed Akata T, Izumi K, Nakashima M: The action of sevoflurane on vascular smooth muscle of isolated mesenteric resistance arteries (part 2): mechanisms of endothelium-independent vasorelaxation. Anesthesiology. 2000, 92: 1441-1453. 10.1097/00000542-200005000-00035.CrossRefPubMed

go back to reference Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB: Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997, 336: 1208-1215. 10.1056/NEJM199704243361703.CrossRefPubMed Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB: Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997, 336: 1208-1215. 10.1056/NEJM199704243361703.CrossRefPubMed

go back to reference van den Brom CE, Bulte CS, Loer SA, Bouwman RA, Boer C: Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism. Cardiovasc Diabetol. 2013, 12: 42-10.1186/1475-2840-12-42.PubMedCentralCrossRefPubMed van den Brom CE, Bulte CS, Loer SA, Bouwman RA, Boer C: Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism. Cardiovasc Diabetol. 2013, 12: 42-10.1186/1475-2840-12-42.PubMedCentralCrossRefPubMed

go back to reference Zhu M, Chen J, Jiang H, Miao C: Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc Diabetol. 2013, 12: 13-10.1186/1475-2840-12-13.PubMedCentralCrossRefPubMed Zhu M, Chen J, Jiang H, Miao C: Propofol protects against high glucose-induced endothelial adhesion molecules expression in human umbilical vein endothelial cells. Cardiovasc Diabetol. 2013, 12: 13-10.1186/1475-2840-12-13.PubMedCentralCrossRefPubMed

go back to reference Xu W-Y, Wang N, Xu H-T, Yuan H-B, Sun H-J, Dun C-L, Zhou S-Q, Zou Z, Shi X-Y: Effects of sevoflurane and propofol on right ventricular function and pulmonary circulation in patients undergone esophagectomy. Int J Clin Exp Pathol. 2014, 7: 272-279.PubMedCentralPubMed Xu W-Y, Wang N, Xu H-T, Yuan H-B, Sun H-J, Dun C-L, Zhou S-Q, Zou Z, Shi X-Y: Effects of sevoflurane and propofol on right ventricular function and pulmonary circulation in patients undergone esophagectomy. Int J Clin Exp Pathol. 2014, 7: 272-279.PubMedCentralPubMed

go back to reference El Messaoudi S, Rongen GA, de Boer RA, Riksen NP: The cardioprotective effects of metformin. Curr Opin Lipidol. 2011, 22: 445-453. 10.1097/MOL.0b013e32834ae1a7.CrossRefPubMed El Messaoudi S, Rongen GA, de Boer RA, Riksen NP: The cardioprotective effects of metformin. Curr Opin Lipidol. 2011, 22: 445-453. 10.1097/MOL.0b013e32834ae1a7.CrossRefPubMed

go back to reference Elmadhun NY, Lassaletta AD, Chu LM, Sellke FW: Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. J Thorac Cardiovasc Surg. 2013, 145: 258-265. 10.1016/j.jtcvs.2012.09.028. discussion 265–6PubMedCentralCrossRefPubMed Elmadhun NY, Lassaletta AD, Chu LM, Sellke FW: Metformin alters the insulin signaling pathway in ischemic cardiac tissue in a swine model of metabolic syndrome. J Thorac Cardiovasc Surg. 2013, 145: 258-265. 10.1016/j.jtcvs.2012.09.028. discussion 265–6PubMedCentralCrossRefPubMed

go back to reference Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N: Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2006, 48: 956-963. 10.1016/j.jacc.2006.04.088.CrossRefPubMed Jadhav S, Ferrell W, Greer IA, Petrie JR, Cobbe SM, Sattar N: Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 2006, 48: 956-963. 10.1016/j.jacc.2006.04.088.CrossRefPubMed

go back to reference Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, Schelbert HR: Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart. 2007, 93: 345-349. 10.1136/hrt.2006.094128.PubMedCentralCrossRefPubMed Schindler TH, Facta AD, Prior JO, Cadenas J, Hsueh WA, Quinones MJ, Schelbert HR: Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes. Heart. 2007, 93: 345-349. 10.1136/hrt.2006.094128.PubMedCentralCrossRefPubMed

go back to reference Maruyama I, Tomiyama Y, Maruyama K, Ojima K, Kobayashi K, Kobayashi M, Yamazaki Y, Kojima M, Shibata N: Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts. Eur J Pharmacol. 2006, 531: 194-200. 10.1016/j.ejphar.2005.11.060.CrossRefPubMed Maruyama I, Tomiyama Y, Maruyama K, Ojima K, Kobayashi K, Kobayashi M, Yamazaki Y, Kojima M, Shibata N: Effects of mitiglinide and sulfonylureas in isolated canine coronary arteries and perfused rat hearts. Eur J Pharmacol. 2006, 531: 194-200. 10.1016/j.ejphar.2005.11.060.CrossRefPubMed

go back to reference Legtenberg RJ, Houston RJF, Heerschap A, Oeseburg B, Smits P: Glibenclamide attenuates ischemia-induced acidosis and loss of cardiac function in rats. Eur J Pharmacol. 2002, 434: 35-42. 10.1016/S0014-2999(01)01483-2.CrossRefPubMed Legtenberg RJ, Houston RJF, Heerschap A, Oeseburg B, Smits P: Glibenclamide attenuates ischemia-induced acidosis and loss of cardiac function in rats. Eur J Pharmacol. 2002, 434: 35-42. 10.1016/S0014-2999(01)01483-2.CrossRefPubMed

go back to reference Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ: Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metab Clin Exp. 2009, 58: 989-994. 10.1016/j.metabol.2009.02.020.CrossRefPubMed Pop-Busui R, Oral E, Raffel D, Byun J, Bajirovic V, Vivekanandan-Giri A, Kellogg A, Pennathur S, Stevens MJ: Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. Metab Clin Exp. 2009, 58: 989-994. 10.1016/j.metabol.2009.02.020.CrossRefPubMed

go back to reference Gejl M, Søndergaard HM, Stecher C, Bibby BM, Møller N, Bøtker HE, Hansen SB, Gjedde A, Rungby J, Brock B: Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012, 97: E1165-E1169. 10.1210/jc.2011-3456.CrossRefPubMed Gejl M, Søndergaard HM, Stecher C, Bibby BM, Møller N, Bøtker HE, Hansen SB, Gjedde A, Rungby J, Brock B: Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes. J Clin Endocrinol Metab. 2012, 97: E1165-E1169. 10.1210/jc.2011-3456.CrossRefPubMed

go back to reference McMahon GT, Plutzky J, Daher E, Bhattacharyya T, Grunberger G, DiCarli MF: Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes. Diabetes Care. 2005, 28: 1145-1150. 10.2337/diacare.28.5.1145.CrossRefPubMed McMahon GT, Plutzky J, Daher E, Bhattacharyya T, Grunberger G, DiCarli MF: Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes. Diabetes Care. 2005, 28: 1145-1150. 10.2337/diacare.28.5.1145.CrossRefPubMed

go back to reference Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994, 94: 2511-2515. 10.1172/JCI117621.PubMedCentralCrossRefPubMed Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P: Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest. 1994, 94: 2511-2515. 10.1172/JCI117621.PubMedCentralCrossRefPubMed

go back to reference Georgescu A, Popov D, Constantin A, Nemecz M, Alexandru N, Cochior D, Tudor A: Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes. Clin Sci. 2011, 120: 463-472. 10.1042/CS20100355.CrossRefPubMed Georgescu A, Popov D, Constantin A, Nemecz M, Alexandru N, Cochior D, Tudor A: Dysfunction of human subcutaneous fat arterioles in obesity alone or obesity associated with Type 2 diabetes. Clin Sci. 2011, 120: 463-472. 10.1042/CS20100355.CrossRefPubMed

go back to reference de Boer MP, Meijer RI, Newman J, Stehouwer CDA, Eringa EC, Smulders YM, Serne EH: Insulin-induced changes in microvascular vasomotion and capillary recruitment are associated in humans. Microcirculation. In press de Boer MP, Meijer RI, Newman J, Stehouwer CDA, Eringa EC, Smulders YM, Serne EH: Insulin-induced changes in microvascular vasomotion and capillary recruitment are associated in humans. Microcirculation. In press

go back to reference Wang T-D, Chen W-J, Cheng W-C, Lin J-W, Chen M-F, Lee Y-T: Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am J Cardiol. 2006, 98: 1057-1062. 10.1016/j.amjcard.2006.05.027.CrossRefPubMed Wang T-D, Chen W-J, Cheng W-C, Lin J-W, Chen M-F, Lee Y-T: Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome. Am J Cardiol. 2006, 98: 1057-1062. 10.1016/j.amjcard.2006.05.027.CrossRefPubMed